hotspot -WSS

hotspot

author：entertainment 2025-09-28 20:33:15 - browse：21

Adobe

At least 224 diabetes patients have been harmed by a software error causing their insulin pumps to spontaneously shut down, the Food and Drug Administration announced in a recall notice on Wednesday.

The product is made by Tandem Diabetes Care, which sells touchscreen insulin pumps and an accompanying app to help dose the medicine. Around 300,000 people use the technology. Tandem found that a bug in the app’s software is causing the app to repeatedly crash and relaunch, draining the insulin pump’s battery through unnecessary Bluetooth communication.

An insulin pump shutting down unexpectedly could kill people, especially if the shutdown occurs while the person is sleeping. There have been no reports of death so far, the FDA said. Tandem users commiserated over the issue on Reddit two months ago, with one user describing waking up at 2 a.m. to a dead pump. “Infuriating,” the user wrote. “Absolutely should be sending a notice out to all customers about this.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Intarcia’s device

hotspot

WSS

Novo Nordisk to expand supply of Wegovy for U.S. patients

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Cybersecurity threat forces Lurie Children's to take systems offline

Congressmen charge Covid hearing ‘could have been an email’

Biotech lab space demand falls sharply

The lessons of Aduhelm, an Alzheimer's drug that was not to be

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

Duchenne breakthrough therapy leaves behind pioneering families

Lasker Awards 2023: Winners in biomedical research

Apple is now the first public company to be valued at $3 trillion

What Congress can do to address the rural doctor shortage

Hollywood unions extend contract negotiations for actors

Biotech lab space demand falls sharply

Drug repurposing or repositioning? The language matters

Experts study whether long Covid risk adds up with each reinfection

23andMe had bad news about my health. I wish a person had delivered it

STAT Virtual Event: Putting AI to the Test

explore

Biotech stock slump in 2023: awaiting the turnaround

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Hearing on Medicare drug price negotiation gets unusually heated

Medical student insurance fails on mental health care coverage

Ukraine and a new approach to mental health in war

Readout LOUD podcast: possible new ALS drug, artificial wombs

explore

hotspot

explore

focus